STEP-HF (semaglutide in patients with heart failure with preserved ejection fraction and obesity) revealed a large reduction in symptoms and physical limitations in patients who received semaglutide 2.4 mg using the Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS)
Yang Y, Li Z, Fan X, Jiang C, Wang J, Rastegar-Kashkooli Y, Wang TJ, Wang J, Wang M
J Clin Endocrinol Metab (2015) 100(8):290917
Morgan CJ
Their benefits are greatest when combined with: Nutrition : A balanced, protein-rich, whole-food diet Exercise : Both resistance training and cardio improve outcomes Supplements and peptides : Options like Omega 1300, MOTS-c, and Tesamorelin may complement GLP-1 therapy Lifestyle : Stress reduction, sleep optimization, and ongoing medical monitoring This integrated approach ensures patients not only lose weight, but also protect their long-term health
Took my third shot this week